AI assistant
BICYCLE THERAPEUTICS PLC — Director's Dealing 2021
Jan 21, 2021
32777_dirs_2021-01-21_d1ddd77f-f693-4701-aff5-eb47d1f70329.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-01-19
Reporting Person: Lee Kevin (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-19 | Ordinary Shares | S | 4529 | $29.1389 | Disposed | 260556 | Direct |
| 2021-01-19 | Ordinary Shares | S | 371 | $30.2193 | Disposed | 260185 | Direct |
| 2021-01-19 | Ordinary Shares | S | 100 | $31.09 | Disposed | 260085 | Direct |
| 2021-01-20 | Ordinary Shares | S | 734 | $31.3272 | Disposed | 259351 | Direct |
| 2021-01-20 | Ordinary Shares | S | 100 | $32.02 | Disposed | 259251 | Direct |
| 2021-01-20 | Ordinary Shares | S | 351 | $33.00 | Disposed | 258900 | Direct |
Footnotes
F1: Shares sold pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.